City
Epaper

COVID-19 situation in Delhi under control, says Satyendar Jain

By ANI | Updated: January 3, 2021 14:10 IST

Coronavirus situation in the national capital is under control, Delhi Health Minister Satyendar Jain said on Sunday.

Open in App

Coronavirus situation in the national capital is under control, Delhi Health Minister Satyendar Jain said on Sunday.

"Currently, Delhi witnessing 494 positive cases which is the lowest number of cases since May 17, 2020. The positivity rate in the national capital has been increased up to 0.3 which means that only seven persons out of 1,000 are being tested positive for COVID-19. However, the testing is happening at a large scale," Jain stated while speaking with .

The Minister also appealed to people to keep wearing masks and take precautions.

Talking about the COVID-19 vaccines that have been approved by the DCGI, the Minister said that the national capital is prepared for the vaccination process in a phased manner.

"In the first phase, healthcare workers and frontline workers will be vaccinated. There are three lakh healthcare workers and six lakh frontline workers in Delhi who will be administered with the COVID-19 vaccine," he said.

"Yesterday a dry-run has been conducted across the national capital in government, private hospitals, and dispensaries. We are preparing for 1,000 centres for the vaccination process. Of which 500 to 600 centres will start for the first phase," he said.

"We have done de-escalations in hospitals three or four days ago. The beds in Delhi hospitals reduced by 2,000 to 2,500 and private hospitals by 5,000 to 6,000. The bed occupancy rate for COVID patients is less than 2,000. Earlier we have around 18,800 beds and now we have 10,000 to 11,000 beds," he said.

COVID-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in emergency situation, said Drugs Controller General of India (DCGI) on Sunday.

"After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situation and permission is being granted to M/s Cadila Healthcare for the conduct of the Phase III clinical trial," said VG Som, DCGI, during a media briefing today.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

NationalHistory-sheeter shot in leg during encounter with police in Chennai, arrested

NationalK'taka Cong crisis: Union Minister Joshi alleges Siddaramaiah, Shivakumar 'purchasing MLAs' for support

BusinessMIT University Sikkim Opens New Campus in Namchi – Complete Guide for Students

BusinessMercury Ev-Tech Limited Strengthens Board, Expands Operations, and Reports Robust Financial Growth

InternationalPM Modi attends G20 Leaders' Summit in Jo'burg, receives warm welcome from SA President Ramaphosa

National Realted Stories

NationalTharoor cites Trump-Mamdani interaction to underline need for political cooperation

NationalAICC sets up 5-member panel to seal seat sharing with DMK for 2026 TN Assembly elections

NationalDefence Secy hails NCC for preparing youth for national service

NationalKerala Minister's brother-in-law claims omission of name from voter list

NationalKarnataka Cong tussle escalates: Mandya MLA backs Shivakumar as CM; cites power-sharing word